Cargando…
Assessing the efficacy of immunotherapy in lung squamous carcinoma using artificial intelligence neural network
BACKGROUND: At present, immunotherapy is a very promising treatment method for lung cancer patients, while the factors affecting response are still controversial. It is crucial to predict the efficacy of lung squamous carcinoma patients who received immunotherapy. METHODS: In our retrospective study...
Autores principales: | Li, Siqi, Li, Wei, Ma, Tianyu, Fu, Siyun, Gao, Xiang, Qin, Na, Wu, Yuhua, Zhang, Xinyong, Wang, Jinghui, Pan, Yuanming, Liu, Zhidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742243/ https://www.ncbi.nlm.nih.gov/pubmed/36518765 http://dx.doi.org/10.3389/fimmu.2022.1024707 |
Ejemplares similares
-
Immunotherapy efficacy predictive tool for lung adenocarcinoma based on neural network
por: Li, Wei, et al.
Publicado: (2023) -
Advances in artificial intelligence to predict cancer immunotherapy efficacy
por: Xie, Jindong, et al.
Publicado: (2023) -
Research progress of extracellular vesicles as biomarkers in immunotherapy for non-small cell lung cancer
por: Ge, Yang, et al.
Publicado: (2023) -
Artificial Intelligence-Assisted Score Analysis for Predicting the Expression of the Immunotherapy Biomarker PD-L1 in Lung Cancer
por: Cheng, Guoping, et al.
Publicado: (2022) -
Applying artificial intelligence for cancer immunotherapy
por: Xu, Zhijie, et al.
Publicado: (2021)